Radiochemotherapy for primary glioblastoma comparing two temozolomide dose regimens.

被引：0
|
作者：
Combs, S. E. [1 ]
Wagner, J. [1 ]
Bischof, M. [1 ]
Welzel, T. [1 ]
Edler, L. [2 ,3 ]
Rausch, R. [2 ,3 ]
Wagner, F. [1 ]
Zabel-du, Bois A. [1 ]
Debus, J. [1 ]
Schulz-Ertner, D. [1 ]
机构：
[1] Univ Klinikum Heidelberg, Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Working Grp, D-6900 Heidelberg, Germany
[3] Deutsch Krebsforschungszentrum, Cent Unit Biostat, D-6900 Heidelberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2008年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens
    Combs, Stephanie E.
    Wagner, Johanna
    Bischof, Marc
    Welzel, Thomas
    Edler, Lutz
    Rausch, Renate
    Wagner, Florian
    Bois, Angelika Zabel-Du
    Debus, Juergen
    Schulz-Ertner, Daniela
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (04): : 999 - 1005
  • [2] Radiochemotherapy with temozolomide for primary glioblastoma multiforme comparing two dose regimens: 50 versus 75?
    Combs, Stephanie
    Wagner, Johanna
    Bischof, Marc
    Debus, Juergen
    Schulz-Ertner, Daniela
    NEURO-ONCOLOGY, 2007, 9 (04) : 582 - 582
  • [3] Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens (vol 71, pg 999, 2008)
    Combs, S. E.
    Wagner, J.
    Bischof, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : 307 - 307
  • [4] RADIOCHEMOTHERAPY IN PATIENTS WITH PRIMARY GLIOBLASTOMA COMPARING TWO TEMOZOLOMIDE DOSE REGIMENS: IS THE SURVIVAL REALLY SO IMPRESSIVE?: IN REGARD TO COMBS ET AL. (INT J RADIAT ONCOL BIOL PHYS 2008;71:999-1005)
    Jalali, Rakesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (05): : 1622 - 1622
  • [5] Effects of a hyperfractionated simultaneous radiochemotherapy with temozolomide (TMZ) in the primary treatment of multiform glioblastoma
    Richter, R.
    Spangenberg, U.
    Friedrich, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 54 - 54
  • [6] Efficacy of different regimens of adjuvant radiochemotherapy for glioblastoma
    Scheda, A.
    Finjap, K.
    Lohr, F.
    Tuettenberg, J.
    Brockmann, M.
    Wenz, F.
    Wenz, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Remarkable Toxicity after Radiochemotherapy for Glioblastoma using Temozolomide
    Niewald, M.
    Berdel, C.
    Fleckenstein, J.
    Ketter, R.
    Ruebe, C.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S46 - S47
  • [8] Topotecan or temozolomide in the simultaneous radiochemotherapy of patients with multiform glioblastoma
    Klautke, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 80 - 81
  • [9] Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
    Victor Lewitzki
    Rainer J. Klement
    Rebekka Kosmala
    Dominik Lisowski
    Michael Flentje
    Bülent Polat
    Radiation Oncology, 14
  • [10] FULL COURSE OF RADIOCHEMOTHERAPY WITH COMBINATION TEMOZOLOMIDE AND BEVACIZUMAB FOR TREATMENT OF INSTANT RECURRENCE OF GLIOBLASTOMA MULTIFORME AFTER INITIAL RADIOCHEMOTHERAPY WITH TEMOZOLOMIDE
    Flowers, Alexandra
    Salner, Andrew
    NEURO-ONCOLOGY, 2010, 12 : 40 - 40
12345